5:20PM AngioDynamics sees Q4 revs above consensus (ANGO) 16.45 +0.55 : Co sees Q4 revs above consensus; sees revs of ~$46.7 mln vs $45.5 mln consensus. Co says, "We executed well during Q4 and made progress toward implementing our growth strategy. With our recent agreement to acquire Diomed's U.S. and U.K. assets, an additional license to certain patents from our settlement with VNUS and the closing of our acquisition of Oncobionic, we believe the co is well-positioned for continued growth in FY09 and beyond. We plan to provide FY09 guidance shortly after we close the Diomed acquisition, which is expected to take place on June 16."
5:05PM Parlux Fragrances reports 2008 (PARL) 3.40 +0.03 : Reports 2008 earnings of $0.24 per share, $0.07 better than the First Call consensus of $0.17; revenues rose 14.0% year/year to $153.7 mln vs the $154.4 mln consensus. Co says, "We are optimistic about the growth and profit potential of the Company in Fiscal 2009 and the future."
4:14PM Focus Media beats by $0.01, reports revs in-line; guides Q2 EPS below consensus, revs below consensus; guides FY08 EPS below consensus, lowers revs below consensus (FMCN) 36.80 +0.95 : Reports Q1 (Mar) earnings of $0.34 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.33; revenues rose 215.0% year/year to $161.6 mln vs the $162 mln consensus. Co issues downside guidance for Q2, sees EPS of $0.40-0.41, excluding non-recurring items, vs. $0.46 consensus; sees Q2 revs of $190-195 mln vs. $201.90 mln consensus. Co lowers revs guidance for FY08; co sees EPS of $1.76-1.91, excluding non-recurring items, vs. $1.95 consensus; co says due to the impact of the recent earthquake in Sichuan province, its 2008 revenue guidance excluding discontinued wireless advertising operations is lowered to $820-850 mln vs. $882.23 mln consensus, down from $860-890 mln.
4:12PM C&D Tech beats by $0.03, beats on revs (CHP) 6.76 +0.42 : Reports Q1 (Apr) earnings of $0.02 per share, $0.03 better than the First Call consensus of ($0.01); revenues rose 21.1% year/year to $93.8 mln vs the $90.7 mln consensus.
4:11PM Mechanical Tech subsidiary, MTI MicroFuel Cells, expands operations into China (MKTY) 0.45 +0.02 : MTI MicroFuel Cells, a subsidiary of Mechanical Technology (MKTY), announces the expansion of its operations into China with the opening of a new representative office in Shanghai. The new office will facilitate MTI Micro's efforts to develop relationships with manufacturers and low-cost component suppliers in China. As part of MTI Micro's business development operations in Asia, the China office will also work to develop new partnerships and help strengthen ongoing OEM relationships. MTI Micro hopes to sign a low-cost manufacturing partner by the end of this year.
4:11PM G-III Apparel beats by $0.07, beats on revs; guides Q2 EPS below consensus, revs in-line; guides FY09 EPS in-line, revs below consensus (GIII) 16.66 +0.75 : Reports Q1 (Apr) loss of $0.42 per share, $0.07 better than the First Call consensus of ($0.49); revenues rose 114.8% year/year to $75.4 mln vs the $60.1 mln consensus. Co issues mixed guidance for Q2, sees EPS of -$0.22 vs. ($0.09) consensus, the increased loss expected during the quarter is due to the seasonal losses incurred from the Andrew Marc acquisition this year; sees Q2 revs of $100.00 mln vs. $112.66 mln consensus. Co issues mixed guidance for FY09, sees EPS of $1.25-1.30 vs. $1.30 consensus; sees FY09 revs of $650-660 mln vs. $673.68 mln consensus.
4:08PM Cascade beats by $0.18, beats on revs (CAE) 50.14 +1.07 : Reports Q1 (Apr) earnings of $1.10 per share, excluding insurance litigation recovery, $0.18 better than the First Call consensus of $0.92; revenues rose 10.6% year/year to $149.9 mln vs the $144.5 mln consensus.
4:08PM Take-Two beats by $0.39, beats on revs; guides Q3 above consensus; guides FY08 EPS above consensus (TTWO) 27.65 +0.34 : Reports Q2 (Apr) earnings of $1.52 per share, excluding non-recurring items, $0.39 better than the First Call consensus of $1.13; revenues rose 162.8% year/year to $539.8 mln vs the $499.1 mln consensus. On Grand Theft Auto IV co says that as of May 31, over 11 million units have been sold in to retailers and approximately 8.5 million units have been sold through to consumers. Co issues upside guidance for Q3, sees EPS of $0.45-0.55 vs. $0.32 consensus; sees Q3 revs of $325-375 mln vs. $322.25 mln consensus. Co issues upside EPS guidance for FY08, sees EPS of $1.65-1.85 vs. $1.53 consensus; sees FY08 revs of $1.4-1.5 bln vs. $1.41 bln consensus. Co said that Fiscal 2008 guidance reflects the release of the first installment of episodic content for Grand Theft Auto IV for Xbox 360 in the first quarter of fiscal 2009 instead of the fourth quarter of fiscal 2008 in order to provide a better balance in their release schedule. (MSFT, ERTS)
4:07PM National Semi beats by $0.08, beats on revs; guides Q1 revs above consensus (NSM) 22.66 +0.78 : Reports Q4 (May) earnings of $0.34 per share, $0.08 better than the First Call consensus of $0.26; revenues rose 1.3% year/year to $462 mln vs the $449.5 mln consensus. Co issues upside guidance for Q1, sees Q1 revs of $460-475 mln vs. $451.22 mln consensus.
4:05PM Optium beats by $0.01, beats on revs; guides Q4 revs in-line (OPTM) 11.58 +0.62 : Reports Q3 (Apr) earnings of $0.07 per share, $0.01 better than the First Call consensus of $0.06; revenues rose 30.4% year/year to $45 mln vs the $44.4 mln consensus. Co issues in-line guidance for Q4, sees Q4 revs of $47-49 mln vs. $46.67 mln consensus. Record revenues for the third quarter were driven by sequential growth across all product lines -- 10Gb/s and 40Gb/s, ROADMs and Analog & Cable TV.
4:05PM Cooper Cos reports EPS in-line, beats on revs; reaffirms FY08 EPS guidance, revs guidance (COO) 41.15 +0.32 : Reports Q2 (Apr) earnings of $0.49 per share, excluding non-recurring items, in-line with the First Call consensus of $0.49; revenues rose 18.7% year/year to $263.5 mln vs the $256.7 mln consensus. Co reaffirms guidance for FY08, sees EPS of $2.10-2.35, excluding non-recurring items, vs. $2.30 consensus; sees FY08 revs of $1.06-1.10 mln vs. $1.07 bln consensus.
9:01AM Nucor raises guidance for Q2 to to $1.75-1.80 from $1.55-1.60 vs $1.69 consensus (NUE) 74.14 : Co said that continued strength in sheet, plate, beam and bar businesses due to the solid global demand for steel and better than expected margins have favorably impacted the second quarter. Upstream and downstream businesses also continue to perform well. (Goes to 100 now)
8:32AM Bio-Reference Labs misses by $0.02, beats on revs (BRLI) 24.47 : Reports Q1 (Apr) earnings of $0.25 per share, $0.02 worse than the First Call consensus of $0.27; revenues rose 23.3% year/year to $75.2 mln vs the $70.1 mln consensus.
8:31AM Ross Stores reports May same store sales of +7.0% vs. +4.5% Briefing consensus (ROST) 35.98 : For the 17 weeks ended May 31, 2008, sales totaled $2.070 bln, an 11% increase over the $1.860 bln in sales for the 17 weeks ended June 2, 2007. Comparable store sales for the 17 weeks ended May 31, 2008 increased 4% over the prior year period.
8:09AM Vail Resorts misses by $0.15, misses on revs (MTN) 49.10 : Reports Q3 (Apr) earnings of $2.24 per share, $0.15 worse than the First Call consensus of $2.39; revenues rose 14.7% year/year to $423.8 mln vs the $469.5 mln consensus. Co sees net income to be at or slightly below the lower end of $117-127 mln range. (Short)
8:07AM Del Monte beats by $0.03, beats on revs; guides FY09 EPS below consensus, revs above consensus (DLM) 8.83 : Reports Q4 (Apr) earnings of $0.29 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.26. Co issues mixed guidance for FY09, sees EPS of $0.58-$0.62, excluding non-recurring items, vs. $0.74 consensus; sees FY09 revs up 5-7%, which equates to $3.92-3.99 bln vs. $3.81 bln consensus. " As a result of the challenging economic environment, the focus on debt repayment, and the planned strategic investments, the Company currently does not plan to repurchase shares during fiscal 2009. The Company does plan to continue to pay a dividend." (Dropped)
7:13AM Dr Pepper Snapple misses by $0.01, beats on revs; guides FY08 EPS above consensus (DPS) 23.90 -0.30 : Reports Q1 (Mar) earnings of $0.40 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of $0.41. Co issues upside guidance for FY08, sees EPS of $1.91, excluding non-recurring items, vs. $1.87 consensus. The Company expects 3% to 5% net sales growth. The diluted earnings per share guidance excludes approximately $0.24 per share comprising separation-related costs ($0.08 per share), bridge loan fees and net interest in connection with our spin-off from Cadbury ($0.06 per share) and restructuring charges related to actions previously announced ($0.10 per share). (Popped)
7:12AM Smithfield Foods misses by $0.06, misses on revs (SFD) 30.13 : Reports Q4 (Apr) earnings of $0.01 per share, $0.06 worse than the First Call consensus of $0.07; revenues rose 20.0% year/year to $2.87 bln vs the $3.55 bln consensus. CEO said, "The current ethanol mandates in place will force this supply diversion from 'corn for food' to 'corn for fuel'. The impact can only be higher food costs for the American consumer... This policy, in my opinion, is a flawed policy and needs to be changed, or food inflation, which has clearly been felt in milk and bread products, has only begun. I strongly urge those in Washington to critically reexamine our ethanol policy to help lessen the burden on the American family already suffering from the effects of higher fuel prices". (Short)
7:02AM Ciena beats by $0.03, beats on revs; reaffirms FY08 revenue guidance (CIEN) 30.46 : Reports Q2 (Apr) earnings of $0.40 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.37; revenues rose 25.1% year/year to $242.2 mln vs the $238.3 mln consensus. Co reaffirms guidance for annual revenue growth of up to 27% in fiscal 2008.
7:02AM Natus Medical updates guidance, gives mixed FY08 guidance and issues Q2 guidance (BABY) 20.89 : Co sees FY08 EPS $0.68-0.70, down from previous gudiance of $0.70-0.72, vs $0.69 First Call consensus; sees revs $163-164 mln, up from previous guidacne of $$161-162 mln, vs $161.73 mln First Call consensus. Co also sees Q2 EPS of $0.14-0.15 vs $0.14 First Call consensus; sees revs $38.3-39.3 mln, slightly higher than previous guidance of $38-39 mln, vs $38.58 mln First Call consensus... The updated guidance reflects the accretive impact of the Sonamed acquisition offset by the dilutive impact of the public offerings. The guidance does not include the impact of one-time charges associated with the public offering, including costs associated with restructuring of the bank debt, one-time charges associated with the Sonamed acquisition, or future restructuring charges exclusive of those previously announced.
No comments:
Post a Comment